Vanessa Wang
Primary Care · Flushing, NYNPI 1285165464
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 451 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,196, 6.5 times the $494 reported in 2021. Among primary care clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 451 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$1K
- Ardelyx, Inc.$861
- Merck$771
- Otsuka America Pharmaceutical, Inc.$515
- Exact Sciences$491
- plus $4K from 27 others
What the payments were for
- Food & beverage$9,624100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 84 | $1,612 |
| Lilly USA, LLC | 47 | $1,100 |
| Ardelyx, Inc. | 38 | $861 |
| Merck | 34 | $771 |
| Otsuka America Pharmaceutical, Inc. | 24 | $515 |
| Exact Sciences | 26 | $491 |
| Amgen | 24 | $479 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $416 |
| Novartis | 15 | $354 |
| Sumitomo Pharma America, Inc. | 13 | $333 |
| AstraZeneca | 14 | $298 |
| Johnson & Johnson | 12 | $257 |
| Novo Nordisk | 13 | $250 |
| Pfizer | 11 | $236 |
| Esperion Therapeutics, Inc. | 12 | $226 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $218 |
| Lundbeck LLC | 10 | $189 |
| GSK | 7 | $149 |
| Radius Health, Inc. | 7 | $143 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $141 |
| Kowa Pharmaceuticals America, Inc. | 7 | $137 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| IBSA Pharma Inc. | 3 | $59 |
| Boehringer Ingelheim | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 2 | $54 |
| Astellas Pharma US Inc | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Amarin Pharma, Inc. | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Oyster Point Pharma, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
How this compares
$9,624 in reported general payments places this provider in the 95th percentile of 239 primary care providers in New York.
Other primary care in Flushing
- Pao-Ju TsengFlushing$6K
- Jian Xin BertolinoFlushing$3K
- Xue GaoFlushing$3K
- Jiyoung YangFlushing$2K
- Dorothy KleinertNew York$27K
- Stephanie KhanForest Hills$16K
- Albert MarcanoJackson Heights$15K
- Elizabeth GattmanJamestown$10K
- Elizabeth SmithWaterloo$9K
- Eric RodriguezSyracuse$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.